- Home
- QIPT vs VANI Comparison
QIPT vs VANI Comparison
Compare QIPT & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- VANI
- Stock Information
- Founded
- QIPT 1993
- VANI 1998
- Country
- QIPT United States
- VANI United States
- Employees
- QIPT N/A
- VANI N/A
- Industry
- QIPT
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- QIPT
- VANI Health Care
- Exchange
- QIPT Nasdaq
- VANI Nasdaq
- Market Cap
- QIPT 92.2M
- VANI 88.3M
- IPO Year
- QIPT N/A
- VANI 2014
- Fundamental
- Price
- QIPT $2.14
- VANI $1.60
- Analyst Decision
- QIPT Buy
- VANI Strong Buy
- Analyst Count
- QIPT 2
- VANI 1
- Target Price
- QIPT $2.85
- VANI $4.00
- AVG Volume (30 Days)
- QIPT 285.8K
- VANI 112.8K
- Earning Date
- QIPT 08-13-2025
- VANI 08-12-2025
- Dividend Yield
- QIPT N/A
- VANI N/A
- EPS Growth
- QIPT N/A
- VANI N/A
- EPS
- QIPT N/A
- VANI N/A
- Revenue
- QIPT $240,848,000.00
- VANI N/A
- Revenue This Year
- QIPT $3.35
- VANI N/A
- Revenue Next Year
- QIPT $5.39
- VANI N/A
- P/E Ratio
- QIPT N/A
- VANI N/A
- Revenue Growth
- QIPT N/A
- VANI N/A
- 52 Week Low
- QIPT $1.35
- VANI $0.91
- 52 Week High
- QIPT $4.07
- VANI $1.80
- Technical
- Relative Strength Index (RSI)
- QIPT 57.85
- VANI 74.93
- Support Level
- QIPT $2.08
- VANI $1.53
- Resistance Level
- QIPT $2.27
- VANI $1.62
- Average True Range (ATR)
- QIPT 0.10
- VANI 0.09
- MACD
- QIPT 0.03
- VANI 0.01
- Stochastic Oscillator
- QIPT 72.63
- VANI 62.96
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.